Clinical Trials Directory

Trials / Unknown

UnknownNCT04636489

Effect of Prebiotics on Blood Glucose Management

An Interventional Study for the Effects of Highland Barley β-glucan on the Management of Glucose Metabolism and Insulin Sensitivity

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
90 (estimated)
Sponsor
Sun Yat-sen University · Academic / Other
Sex
All
Age
30 Years – 65 Years
Healthy volunteers
Accepted

Summary

This survey is designed to investigate the effect of highland barley β-glucan supplementation on the regulatory of blood glucose, gut microbiota and cardiovascular risk fators in subjects with hyperglycemia.

Detailed description

Highland barley β-glucan belongs to the group of prebiotics and has been found to be associated with multiple health benefits. However, its protective role in subjects with hyperglycemia are remain unclear. This study aims to examine the effect of 8-week prebiotics supplementation on glucose management in subjects with hyperglycemia. By understanding the mechanism by which prebiotics exert the beneficial effects, we can better control the rising prevalence of hyperglycemia, which is a major risk factor for cardiovascular diseases.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTHighland barley β-glucan dietary supplement100 mL oral liquid mainly containing highland barley β-glucan once daily for 8 weeks
OTHERPlacebo controlsPlacebo with a similar appearance and taste to highland barley β-glucan supplement

Timeline

Start date
2020-11-30
Primary completion
2024-12-31
Completion
2024-12-31
First posted
2020-11-19
Last updated
2022-05-05

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT04636489. Inclusion in this directory is not an endorsement.